Lili Wang1,2,3,4,5,6,7,8,9,10, C. B. Collins1,2,3,4,5,6,7,8,9,10, Edward J. Kelly1,2,3,4,5,6,7,8,9,10, Xiaoyan Chu1,2,3,4,5,6,7,8,9,10, Adrian S. Ray1,2,3,4,5,6,7,8,9,10, Laurent Salphati1,2,3,4,5,6,7,8,9,10, Guangqing Xiao1,2,3,4,5,6,7,8,9,10, C. Lee1,2,3,4,5,6,7,8,9,10, Yurong Lai1,2,3,4,5,6,7,8,9,10, Mingxiang Liao1,2,3,4,5,6,7,8,9,10, Anita Mathias1,2,3,4,5,6,7,8,9,10, Raymond Evers1,2,3,4,5,6,7,8,9,10, W. Griffith Humphreys1,2,3,4,5,6,7,8,9,10, Cornelis E. C. A. Hop1,2,3,4,5,6,7,8,9,10, Sean C. Kumer1,2,3,4,5,6,7,8,9,10, Jashvant D. Unadkat1,2,3,4,5,6,7,8,9,10
1Department of Pharmaceutics, University of Washington, Seattle, Washington (L.W., C.C., E.J.K., J.D.U.)
2Department of Surgery, University of Kansas Medical Center, Kansas City, Kansas (S.C.K.)
3Departments of Clinical Pharmacology and Drug Metabolism and Pharmacokinetics, Gilead Sciences, Inc., Foster City, California (A.S.R., A.M.)
4Drug Metabolism and Pharmacokinetics, Genentech, South San Francisco, California (L.S., C.E.C.A.H.)
5Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (Y.L.,W.H.)
6Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Ardea Biosciences, Inc., San Diego, California (C.L.)
7Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co., Kenilworth, New Jersey (R.E.)
8Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co., Rahway, New Jersey (X.C.)
9Preclinical PK and In Vitro ADME, Biogen, Cambridge, Massachusetts (G.X.)
10Takeda Pharmaceuticals International Co., Cambridge, Massachusetts (M.L.)
